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ABSTRACT
Background Owing to the increase in the older 
population and the increased life span, the number of 
patients with oral multiple primary carcinomas will 
increase. Predicting the second and third carcinoma 
clinically is difficult, and the presence of second or third 
carcinomas is a factor that determines the prognosis of 
oral carcinoma. In this study, we examined the clinical 
features of oral multiple primary carcinomas treated in 
our department.
Methods We retrospectively reviewed the medical 
records of patients with oral squamous cell carcinoma 
who underwent radical treatment at and were followed 
by the Department of Oral and Maxillofacial Surgery, 
Tottori University Hospital from January 2003 to 
October 2017.
Results This study included 261 patients: 241 patients 
had oral single primary carcinoma and 20 patients 
had oral multiple primary carcinomas. Oral multiple 
primary carcinomas showed female predilection and 
occurred more frequently in the lower gingiva and sig-
nificantly less frequently in the tongue (P < 0.01). Oral 
multiple primary carcinomas showed a significantly 
higher recurrence rate (P < 0.01). The 5-year overall 
survival of oral single primary carcinoma patients was 
88.0% compared with 95% for oral multiple primary 
carcinomas, with no significant difference (log rank test, 
P = 0.54). However, the 15-year survival rate dropped to 
28.1% in oral multiple primary carcinomas. The cumu-
lative disease incidence rates of metachronous second 
primary carcinoma from first carcinoma at 5 years and 
10 years were 3.45% and 5.36%, respectively.
Conclusion Oral multiple primary carcinomas rarely 
occur in the tongue. The 5-year survival rate showed 
no difference between single and multiple carcinoma 
patients, but over longer observation, the prognosis of 
multiple carcinoma was poor owing to a high recur-
rence rate. Because of the high recurrence rate and risk 
of further metachronous carcinoma in oral multiple 
primary carcinomas, longer-term follow-up is required.
Key words carcinoma, squamous cell; mouth neo-
plasms; neoplasms, multiple primary
Oral carcinoma is a major health problem in certain 
parts of the world. Globally, there are around 270,000 
new cases annually and 145,000 deaths related to oral 
carcinoma.1 Squamous cell carcinoma is the most 
frequent type, accounting for at least 90% of all oral 
carcinomas.2, 3 Because of the increase in the older 
population, the increased lifespan and the improvement 
of treatment results of oral carcinoma, the number of 
cases with oral multiple primary carcinomas will also 
increase. Predicting the second and third carcinoma 
clinically is difficult and the presence of second or third 
carcinomas is a factor that determines the prognosis of 
oral carcinoma.4–9 Also, there is not much literature in 
Japan comparing the clinical features of oral multiple 
primary carcinomas with oral single primary carci-
noma. In this study, we compared the clinical features 
of oral multiple primary carcinomas treated in our de-
partment with those of oral single primary carcinoma.
MATERIALS AND METHODS
We retrospectively reviewed the medical records of 
patients with oral squamous cell carcinoma who under-
went radical treatment (including surgical treatment, 
radiotherapy, and chemotherapy) at, and were followed 
up by, the Department of Oral and Maxillofacial 
Surgery, Tottori University Hospital from January 2003 
to October 2017. The observation endpoint was set as 
October 31, 2018 so that the observation period would 
be one year or longer for all cases including cases of oral 
single primary carcinoma. Neck dissection was per-
formed for both single and multiple primary carcinoma 
when cervical lymph node metastasis was clinically 
suspected.
Patients treated at other facilities, patients who 
were difficult to evaluate pathologically, or patients 
who did not provide consent were excluded. The study 
protocol was approved by our institution and was in 
accordance with the Declaration of Helsinki (19A128).
Oral single primary carcinoma was defined as 
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carcinoma that developed only a single lesion during 
the follow-up period. Oral multiple primary carcinomas 
were defined according to criteria modified from 
those of Warren and Gate in 1932 and based on the 
‘General Rules for Clinical and Pathological Studies 
on Oral Cancer’ edited by the Japan Society for Oral 
Tumors.10, 11 Specifically, multiple oral carcinomas 
were defined as cases in which two or more primary 
carcinomas were confirmed in the oral cavity and that 
satisfied the following conditions: (i) the site by Union 
for International Cancer Control classification was 
different, (ii) the lesions were recognized on opposite 
sides in the same site, (iii) if ipsilateral, there was no 
continuity between the two lesions and they were clini-
cally more than 2.0 cm apart, and (iv) each lesion was 
histopathologically confirmed to be carcinoma. Multiple 
primary carcinomas were categorized as synchronous 
carcinomas, metachronous carcinomas, or synchrony 
and metachronous carcinomas. Synchronous carcinoma 
was a carcinoma diagnosed in less than a year after 
the initial diagnosis, and metachronous carcinoma 
was diagnosed after a period 1 year or more. If both 
synchronous and metachronous were present, the case 
was considered as synchrony and metachronous carci-
noma. In the case of synchronous multiple carcinomas, 
the stage was determined based on the most advanced 
carcinoma at the time of initial diagnosis.
Carcinoma that was not more than 2.0 cm from the 
first carcinoma or carcinoma that occurred on the same 
side of the same site was defined as local recurrence. In 
cases in which it was difficult to judge whether the car-
cinomas were 2.0 cm apart, the lesion was considered as 
local recurrence. Carcinoma in situ was also treated as 
carcinoma in the study. In cases of a metachronous sec-
ond or third carcinoma treated during the target period 
and that were treated as oral primary carcinoma at our 
department before the study period, we considered them 
as eligible cases.
We compared clinical data such as age, sex, and tu-
mor location, smoking history and drinking habits for oral 
single and multiple primary carcinomas using the Mann–
Whitney U test, Chi-square test, or Fisher’s exact test.
Prognosis was examined using disease specific 
survival and overall survival using the Kaplan–Meier 
curve, and the log rank test was used to evaluate the 
statistically significant differences. Recurrence rate and 
cervical lymph node late metastases were also counted. 
In case of metachronous multiple primary carcinomas, 
recurrence after secondary carcinoma was also counted
Statistical analysis was performed using SPSS 
ver.25 software (IBM SPSS, Armonk, NY). P < 0.05 
was considered statistically significant.
RESULTS
This study enrolled 284 patients with oral squamous cell 
carcinoma who underwent curative treatment. Among 
these patients, 13 patients were excluded because they 
could not be monitored during the observation period, 
and 10 patients had uncontrolled tumors with initial 
treatment. Thus, we analyzed 261 patients: 241 patients 
were single primary carcinoma cases and 20 patients 
were multiple primary carcinomas cases. The median 
duration of follow-up was 53 (range, 4–342) months.
Of the 20 cases with oral multiple primary car-
cinomas, 6 (30%) showed synchronous first multiple 
primary carcinomas, 7 (35%) had metachronous 
second multiple primary carcinomas, 1 (5%) showed 
synchronous second multiple carcinomas, 3 (15%) had 
metachronous third multiple carcinomas, and 3 (15%) 
had fourth multiple carcinomas (Fig. 1).
Patient characteristics
The mean age at first diagnosis was 69.5 (range, 42–84) 
years in the oral single primary carcinoma group and 
67.9 (range, 30–93) in the oral multiple primary carcino-
mas group.
There were 4 men and 16 women in the oral mul-
tiple primary carcinomas group and 141 men and 100 
women in the oral single primary carcinoma group. Oral 
multiple primary carcinomas occurred more frequently 
in women than in men, while single primary carcinoma 
occurred more frequently in men than in women (P = 
0.041, chi-square test).
As for drinking habit, for oral single primary carci-
noma, 101 had a drinking habit and 123 did not (17 were 
unknown). With oral multiple primary carcinomas, 5 
had a drinking habit and 15 had no drinking habits, 
there was no significant difference between the two 
groups (P = 0.041, chi-square test).
Regarding smoking history, 127 cases of oral 
single primary carcinoma had a smoking history and 98 
cases had no smoking history (16 cases were unknown). 
In oral multiple primary carcinomas, 4 had a history 
of smoking and 16 had no history of smoking. The 
smoking rate was significantly lower in oral multiple 
carcinomas (P = 0.0017, chi-square test).
Tumor location
The tumor locations are shown in Table 1. The tongue 
was the most common location in oral single primary 
carcinoma (113/241, 46.9%), followed by lower gingiva 
(52/241, 21.6%). In oral multiple primary carcinomas, 
the most common location was lower gingiva (8/20, 
40%), followed by buccal mucosa (6/20, 30%). Normal 
oral mucosa is classified into three types: masticatory 
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mucosa (lower gingiva, upper gingiva, hard palate), 
coated mucosa (buccal mucosa, floor of mouth), and 
special mucosa (tongue),12 and the sites of occurrence 
were divided into groups according to their clas-
sification. (Table 2). In multiple primary carcinomas, 
a significant number of cases occurred in the lower 
gingiva, upper gingiva, and hard palate compared with 
other groups (P = 0.041, chi-square test; in cases of 
simultaneous multiple cancers, each site was recorded). 
In addition, when buccal mucosa and floor of the mouth 
were compared with other groups, buccal mucosa and 
floor of the mouth had significantly higher incidence of 
oral multiple primary carcinomas (P = 0.025, Fisher’s 
exact test). Furthermore, compared with other parts 
of the tongue, the tongue had a significantly lower 
incidence of oral multiple primary carcinomas (P < 0.01, 
chi-square test).
T and N classification
T and N classifications are shown in Table 3. In oral 
single primary carcinoma, the frequency of Tis and 
T1–2 cases were 76.3% (184/241) and T3–4 cases were 
23.7% (57/241). In oral multiple primary carcinomas, 
the frequency of Tis and T1–2 cases were 50.0% (10/20) 
and T3–4 were also 50.0% (10/20). The rate of ad-
vanced carcinoma was higher in oral multiple primary 
carcinomas than oral single primary carcinoma, but the 
Mann–Whitney U test did not show significant differ-
ences between oral single primary carcinoma and oral 
multiple primary carcinomas in T classification (P = 
Fig. 1. Flow chart of patients with single or multiple primary oral carcinomas. Multiple primary carcinomas were 
categorized by the number of carcinomas, and synchronous or metachronous. SCC, squamous cell carcinoma.
Table 1. Primary site of oral single primary carci-
noma and oral multiple primary carcinomas at the 
first occurrence
Single primary SCC, 
n = 241
Multiple primary SCC 
at the first occurrence, 
n = 20
Lower gingiva 52 6
Lower gingiva+ 
Buccal mucosa 0 1
Lower gingiva+ 
Tongue 0 1
Buccal mucosa 19 3
Buccal mucosa+ 




Hard palate 0 1
Upper gingiva 23 3
Floor of month 28 2
Tongue 113 0
Tongue+ 
Hard palate 0 1
Hard palate 6 0
SCC, squamous cell carcinoma.
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0.054).
Only 5.0% (1/20) of oral multiple primary carcino-
mas showed cervical lymph node metastasis compared 
with 17.9% (43/241) in oral single primary carcinoma. 
There was no significant difference between the groups 
(P = 0.33, Fisher’s exact test).
Local recurrence and postoperative cervical lymph 
node metastasis
Local recurrence was observed in 80.0% (16/20) of 
patients with oral multiple primary carcinomas, com-
pared with 17.0% (41/241) of patients with oral single 
primary carcinoma. The rate of local recurrence was 
significantly higher in oral multiple primary carcinomas 
than in oral single primary carcinoma (p < 0.01, Fisher’s 
exact test) (Fig. 2). Postoperative cervical lymph node 
metastasis was observed in 25.0% (5/20) of patients with 
oral multiple primary carcinomas compared with 18.3% 
(44/241) of patients with oral single primary carcinoma. 
There was no significant difference between them (P = 
0.55, Fisher’s exact test) (Fig. 3).
Disease specific survival and Overall survival
The disease specific survival of patients with single 
primary carcinoma at 5 years and 10 years was 90.2% 
and 86.3%, respectively, while the overall survival of 
patients with multiple primary carcinomas at 5 years 
and 10 years was 95.0% and 74.8%, respectively. There 
was no significant difference in disease free survival 
between the two groups (log rank test, P = 0.103) (Fig. 
4).
The overall survival of patients with single primary 
carcinoma at 5 years and 10 years was 88.0% and 
85.1%, respectively, while the overall survival of pa-
tients with multiple primary carcinomas at 5 years and 
10 years was 95.0% and 74.8%, respectively. There was 
no significant difference in overall survival between the 
two groups (log rank test, P = 0.54) (Fig. 5).
However, the 15-year survival rate dropped to 
28.1% in patients with oral multiple primary carcinomas 
in disease specific survival and overall survival.
Cumulative disease incidence rate of metachro-
nous second multiple primary carcinomas
The cumulative disease incidence rates of metachronous 
second primary carcinoma from first carcinoma at 5 
years and 10 years were 3.45% and 5.36% (Fig. 6).
DISCUSSION
The mechanism underlying the onset of oral multiple 
primary carcinomas is unknown, but some hypotheses 
have been reported. One of the most common hypoth-
eses is the concept of “field cancerization,” introduced 
by Slaughter et al in 1953.13 The concept is that carci-
noma develops in multiple locations owing to long-term 
Table 2. Comparison of sites in single primary carcinoma and multiple primary carcinomas (synchronous mul-
tiple primary carcinomas were included for each site)
Single primary SCC,  
n = 241
Multiple primary SCC at the first occurrence,  
n = 26 P value
Lower gingiva, Upper gingiva, Hard plate  
(Masticatory mucosa) 81 14 P = 0.041
Buccal mucosa, Floor of mouth, Tongue 160 12
Buccal mucosa, Floor of mouth (Coated mucosa) 47 9 P = 0.025
Lower gingiva, Upper gingiva, Hard plate, Tongue 194 17
Tongue (Special mucosa) 113 3 P < 0.001
Lower gingiva, Buccal mucosa, Upper gingiva,  
Floor of mouth, Hard palate 228 21
SCC, squamous cell carcinoma.
Table 3. Tumor staging of oral single primary carci-
noma and oral multiple primary carcinomas
Single primary SCC,  
n = 241
Multiple primary SCC at 










SCC, squamous cell carcinoma.
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exposure to a common cancer-inducing factors. Several 
researchers have reported the relationship between 
genes and multiple head and neck carcinomas based 
on this concept.14, 15 For example, Tabor et al reported 
that the first primary tumor and second primary tumor 
develop from a single contiguous genetically altered 
field and thus have a common clonal origin.15 However, 
oral multiple primary carcinomas are thought to occur 
due to multiple factors including environmental factors 
as well as the above-mentioned genetic factors.3–7 For 
example, tobacco, which is an important risk factor for 
oral carcinoma,16, 17 did not affect the occurrence of oral 
secondary carcinomas. Tomek et al reported that the 
frequency of secondary carcinoma in head and neck 
carcinoma that occurred in patients who continued 
smoking after the diagnosis of primary carcinoma did 
not differ from those in the group of patients who quit 
smoking, indicating no association between the occur-
rence of secondary carcinoma and tobacco.18 Because 
there are many unclear points about oral multiple 
Fig. 2. Cumulative local recurrence rates in patients with oral single primary carcino-
ma and those with oral multiple primary carcinomas. The rate of local recurrence was 
significantly higher in oral multiple primary carcinomas than in oral single primary 
carcinoma (P < 0.01, Fisher’s exact test).
Fig. 3. Cumulative incidence of late metastasis to cervical lymph nodes with oral 
single primary carcinoma and those with oral multiple primary carcinomas. There 
was no significant difference between single primary carcinoma and oral multiple 
primary carcinomas (P = 0.55, Fisher’s exact test).
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primary carcinomas, we performed a comparative study 
of oral multiple primary carcinomas based on clinical 
data, and the characteristics were investigated.
In our report, females were significantly more fre-
quently present than males in the oral multiple primary 
carcinoma group. Some previous studies reported that 
oral multiple primary carcinomas developed in males 
only,4, 5 while others showed they were more common 
in females.6–8 Although our data showed a significantly 
increased frequency among females, it is not possible to 
conclude that there is a sex difference in oral multiple 
primary carcinomas because the sex difference varies 
greatly from report to report.
The mean patient age at first diagnosis was 67.9 
(range, 42–84) years for patients with oral multiple 
primary carcinomas, which is younger than 69.5 (range, 
30–93) years for patients with oral single primary car-
cinoma. Other studies reported the mean age of patients 
with oral multiple primary carcinomas as 52.2–68.3 
years.4, 6–8 Mochizuki et al reported that the age of 
patients with oral multiple primary carcinomas was 
significantly higher than that of patients with oral single 
Fig. 4. Disease specific survival of patients with oral single primary carcinoma and 
those with oral multiple primary carcinomas. There was no significant difference 
between single primary carcinoma and oral multiple primary carcinomas (P = 0.103, 
log rank test).
Fig.5. Overall survival rates of patients with oral single primary carcinoma and those 
with oral multiple primary carcinomas. There was no significant difference between 
single primary carcinoma and oral multiple primary carcinomas (P = 0.54, log rank 
test).
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primary carcinoma (68.3 vs. 61.6 years),6 which was not 
consistent with our data. Thus, patient age on diagnosis 
appears to vary depending on the report. According to 
our study and other reports, the peak age of onset of oral 
multiple primary carcinomas was about the same as the 
peak age of onset of oral single primary carcinoma.
Regarding drinking habits, there was no significant 
difference between oral single primary carcinoma and 
oral multiple primary carcinomas, and it seems that 
there was no correlation between the drinking habits 
and the appearance of multiple primary carcinomas.
Smoking history was significantly lower in oral 
multiple primary carcinomas. Although it is unlikely 
that smoking has a preventive effect on oral multiple pri-
mary carcinomas, at least it was not possible to conclude 
that smoking induces oral multiple primary carcinomas, 
which was consistent with previous literature.17
In our report, the most common site of oral multi-
ple primary carcinomas was lower gingiva, followed by 
the buccal mucosa. We found significantly fewer cases 
in the tongue in oral multiple primary carcinomas. In 
other studies, oral multiple primary carcinomas tended 
to be less frequent in the tongue compared with oral 
single primary carcinoma, while oral multiple primary 
carcinomas were more common in the gingiva and 
buccal mucosa,5, 6, 8 which is consistent with our report. 
The cervical lymph node metastasis rate was lower in 
oral multiple primary carcinomas than in oral single 
primary carcinoma. The reason for the location of oral 
multiple primary carcinomas differing from the location 
of oral single primary carcinoma is unclear. However, 
this may explain the low proportion of cervical lymph 
nodes in oral multiple primary carcinomas. Carcinoma 
that develops in the special mucosa or coated mucosa 
tends to metastasize to cervical lymph nodes.6 In our 
report, in oral multiple primary carcinomas, the gingiva 
and hard palate covered by masticatory mucosa were 
significantly more numerous than other sites. The differ-
ence in the incidence of cervical lymph node metastasis 
between oral multiple primary carcinomas and oral 
single primary carcinoma may be due to the difference 
in the site where the primary carcinoma occurs.
Although there was no significant difference in 
T and N classification between single and multiple 
carcinomas, patients with oral multiple primary 
carcinomas had a significantly higher recurrence rate 
than those with oral single primary carcinoma. Oral 
multiple primary carcinomas have been reported to be 
related to leukoplakia, lichen planus, and oral epithelial 
dysplasia,8, 19 and it is possible that the dysmorphic cells 
remained after resection and recurrence occurred. For 
other reason, by definition, if the distance between the 
site of the first lesion and the site of the next lesion is not 
more than 2 cm or if they are on the same side and have 
the same name, the secondary lesion is considered a 
recurrence. Carcinoma, that do not originate from atypi-
cal cells or cancer cells that remain after surgery, and 
that are formed after surgery based on “field canceriza-
tion” are also considered to be recurrent if it is close to 
the first carcinoma or in the same name and site on the 
same side as the first carcinoma.
Kao et al. reported that there are no special treat-
ments for oral multiple primary carcinomas.4 Surgery 
is the standard treatment for single primary oral carci-
noma in resectable cases,20 and the same is true for oral 
multiple primary carcinomas. Although a large margin 
of resection increases the severity of dysfunction, it is 
very important to have a sufficient margin because local 
recurrence in oral squamous cell carcinomas is related 
poor prognosis.4 To avoid secondary or tertiary primary 
carcinoma, secure resection is desirable.
Radiation therapy is not recommended for re-
sectable oral carcinoma. Hashibe et al. reported that 
radiation therapy for a first oral carcinoma was a risk 
factor of second primary carcinoma.21 The reason for 
this is that although the carcinoma of patients who 
underwent radiation treatment was at an advanced 
stage, the recurrence rate of these patients was high. In 
addition, no report has examined the effect of radiation 
therapy on preventing the appearance of secondary 
and tertiary carcinomas. Therapeutic radiotherapy of 
resectable oral carcinoma or prophylactic radiotherapy 
of secondary carcinoma is not recommended and may 
cause carcinoma in other sites. Radiation therapy should 
Fig. 6. Cumulative incidence of metachronous secondary carci-
noma occurrence. The incidence rates were 3.45% and 5.36% at 5 
and 10 years from first carcinoma, respectively.
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be done when the tumor is unresectable or at high risk 
of recurrence, such as when the margin is positive and 
upon multiple lymph node metastases after surgery, and 
should be carefully considered when the recurrence risk 
is not high.
Previous studies reported no significant difference 
in overall survival between patients with oral multiple 
primary carcinomas and oral single primary carci-
noma.21 Similar to other reports,4, 6 the 5-year survival 
rate for patients with oral multiple primary carcinomas 
in this study was not low, but the 15-year survival rate 
of patients with multiple primary carcinomas dropped 
to 28.1%. Although there is a limitation that there were 
few long-term observation cases in oral single primary 
carcinoma compared with oral multiple primary carci-
nomas, we consider that the long-term prognosis of oral 
multiple primary carcinomas was poor for the following 
reasons. As described above, the recurrence rate is high 
in oral multiple primary carcinomas. Local recurrence 
of oral carcinoma is often not fatal if it is resectable, but 
dysphagia due to additional resection for local recur-
rence may lead to pneumonia, and a long-term cancer-
bearing state at the primary site due to recurrence 
makes metastasis to cervical lymph nodes and distant 
organs more likely, leading to poor prognosis. Other 
reasons for the low 15-year survival rate may be that 
these patients do not receive treatment at confirmation 
of recurrence or appearance of multiple carcinomas due 
to the older age of patients or the onset of dementia.
The cumulative disease incidence of metachronous 
secondary carcinomas at 5 years and 10 years after the 
initial cancer was 3.45% and 5.36%, respectively, and a 
proportion of metachronous carcinomas was observed. 
Even if the progress of the primary site is good, oral 
carcinoma is at risk for developing multiple primary car-
cinomas, and long-term follow-up is considered useful 
for early detection of oral multiple primary carcinomas.
In conclusion, oral multiple primary carcinomas 
frequently occur in the lower gingiva and buccal mu-
cosa and occur less frequently in the tongue. Although 
the 5-year survival rate of oral multiple primary 
carcinomas was not lower than that of single carcinoma, 
over longer periods of time, the recurrence rate was 
significantly higher in oral multiple primary carcinomas 
and the prognosis was worse over the longer term. Oral 
multiple primary carcinomas have a high recurrence 
rate, and there is a risk of further metachronous carcino-
mas occurring with oral multiple primary carcinomas. 
Oral metachronous multiple primary carcinomas can 
occur 5 or 10 years after the initial treatment of oral 
carcinoma treatment, so long-term follow-up of oral 
carcinoma helps early detection of oral multiple primary 
carcinomas.
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